Hinge Health (HNGE) CFO James Budge updates holdings after 20,000-share move

Rhea-AI Filing Summary

Hinge Health, Inc. Chief Financial Officer James Budge reported a change in his holdings of the company’s Class A common stock. On 12/11/2025, he disposed of 20,000 shares at a reported price of $0 under transaction code G, leaving him with 451,665 shares of Class A common stock held directly after the transaction. This filing was made as a Form 4 by a single reporting person.

Insider Trade Summary

20,000 shares gifted

Mixed 1 txn

Insider Budge James

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Gift	Class A Common Stock	20,000	$0.00	--

Holdings After Transaction: Class A Common Stock — 451,665 shares (Direct)

Footnotes (1)

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Budge James

(Last) (First) (Middle)

C/O HINGE HEALTH, INC.

455 MARKET STREET, SUITE 700

(Street)

SAN FRANCISCO CA 94105

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Hinge Health, Inc. [ HNGE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
12/11/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	12/11/2025		G		20,000	D	$0	451,665	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ James Budge	12/12/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Hinge Health (HNGE) disclose in this Form 4?

The Form 4 reports that Chief Financial Officer James Budge disposed of 20,000 shares of Hinge Health, Inc. Class A common stock on 12/11/2025 at a reported price of $0 under transaction code G.

How many Hinge Health (HNGE) shares does the CFO hold after this transaction?

After the reported transaction, Chief Financial Officer James Budge beneficially owns 451,665 shares of Hinge Health, Inc. Class A common stock, held directly.

What is the role of the reporting person in Hinge Health (HNGE)?

The reporting person, James Budge, is an officer of Hinge Health, Inc., serving as the company’s Chief Financial Officer.

Was this Hinge Health (HNGE) Form 4 filed by one or multiple reporting persons?

The Form 4 was indicated as being filed by one reporting person, specifically Chief Financial Officer James Budge.

What type of security was involved in the Hinge Health (HNGE) insider transaction?

The transaction involved Class A common stock of Hinge Health, Inc., as listed in Table I of the Form 4.

When was the earliest transaction date reported in this Hinge Health (HNGE) Form 4?

The earliest transaction date reported is 12/11/2025, which is shown as the transaction date for the Class A common stock disposition.